Priorities for medtech under new German reimbursement supremo
This article was originally published in Clinica
Executive Summary
The Gemeinsamer Bundesausschuss ( G-BA) is Germany�s healthcare products reimbursement authority, and as such, the key decision-maker bar none for device manufacturers seeking to enter a market valued at €25bn*.